64

DAFTAR PUSTAKA

1. Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, et al.

Epidemiology and outcome of severe pneumococcal pneumonia admitted to

intensive care unit: a multicenter study. Critical care. 2012;16(4):R155.

2. File TM. Community-acquired pneumonia. Lancet. 2003; 362:1991

3. Centers for Disease Control and Prevention. FastStats :

Pneumonia(Internet).2013(updated 2013 April 5; cited 2014 Januari

10).Available from : www.cdc.gov/nchs/fastats/pneumonia.htm

4. Ewig, S., Birkner, N., Strauss, R., Schaefer, E., Pauletzki, J., Bischoff, H. et

al. New perspectives on community-acquired pneumonia in 388406 patients.

Results from a nationwide mandatory performance measurement programme

in healthcare quality.Thorax.2009; 64: 1062–1069

5. Navdeep K. Brar M, Michael S. Niederman, MD. Management of

community-acquired Pneumonia. Therapeutic Advances in Respiratory

Disease. 2011;5(1):61 - 78.Available from : www.medscape.com

6. Pokja Infeksi Perhimpunan Dokter Paru Indonesia.Pneumonia Komunitas :

Pedoman Diagnosis dan Penatalaksanaan Di Indonesia.2003

7. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean

NC, et al. Infectious Diseases Society of America/American Thoracic Society

consensus guidelines on the management of community-acquired pneumonia

in adults. Clinical infectious diseases. 2007;44(Supplement 2):S27-S72.

8. Ho P-L, Cheng VC-C, Chu C-M. Antibiotic resistance in community-acquired

pneumonia caused by Streptococcus pneumoniae, methicillin-resistant

Staphylococcus aureus, and Acinetobacter baumannii. CHEST Journal.

2009;136(4):1119-27.

9. Ramirez JA, Anzueto AR. Changing needs of community-acquired

pneumonia. Journal of antimicrobial chemotherapy. 2011;66(suppl 3):iii3-iii9.

65

10. Arancibia F, Ewig S, Martinez JA, Ruiz M, Bauer T, Marcos MA, et al.

Antimicrobial treatment failures in patients with community-acquired

pneumonia: causes and prognostic implications. American journal of

respiratory and critical care medicine. 2000;162(1):154-60.

11. Fine MJ, Pratt HM, Obrosky DS, Lave JR, McIntosh LJ, Singer DE, et al.

Relation between length of hospital stay and costs of care for patients with

community-acquired pneumonia. The American journal of medicine.

2000;109(5):378-85.

12. Bartolome M, Almirall J, Morera J, Pera G, Ortun V, Bassa J, et al. A

population-based study of the costs of care for community-acquired

pneumonia. European Respiratory Journal. 2004;23(4):610-6.

13. Kementerian Kesehatan Republik Indonesia.Triple Burden Ancam

Lansia.Jakarta : Pusat Komunikasi Publik Sekretariat Jenderal Kementerian

Kesehatan RI;2013.Available from : www.depkes.go.id

14. Sato R, Rey GG, Nelson S, Pinsky B. Community-acquired pneumonia

episode costs by age and risk in commercially insured US adults aged≥ 50

years. Applied health economics and health policy. 2013;11(3):251-8.

15. Dahlan Z. Pneumonia.Buku Ajar Ilmu Penyakit Dalam. 2. 4 ed. In: W.Sudoyo

A, Setiyohadi B, Alwi I, K. MS, Setiati S, editors. Jakarta: Pusat Penerbitan

Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas

Indonesia; 2006. p. 964 - 71.

16. Cascini S AN, Incalzi RA, Pinnarelli L, Mayer F, Arcà M, Fusco D, Davoli

M. Pneumonia burden in elderly patients: a classification algorithm using

administrative data. BMC Infectious Disease. 2013;13(559).

17. Lawrence M T, Jr., J.McPhee S, A.Papadakis M. Diagnosis dan Terapi

Kedokteran Penyakit Dalam. 1 ed. Jakarta: Salemba Medika; 2002. 100 - 10

p.

66

18. Armitage K, Woodhead M. New guidelines for the management of adult

community-acquired pneumonia. Current opinion in infectious diseases.

2007;20(2):170-6.

19. Gutierrez F, Masia M, Rodriguez J, Mirete C, Soldan B, Padilla S, et al.

Epidemiology of community‐acquired pneumonia in adult patients at the

dawn of the 21st century: a prospective study on the Mediterranean coast of

Spain. Clinical microbiology and infection. 2005;11(10):788-800.

20. American Lung Association(Internet).Chicago : Understanding

Pneumonia;c2014(cited 2014 Januari 10).Available from :

www.lung.org/lung-disease/pneumonia/understanding-pneumonia.html

21. Tsai-Ling Lauderdale F-YC, Ren-Jy Ben, Hsiao-Chuan Yin, et al. Etiology of

community acquired pneumonia among adult patients requiring

hospitalization in Taiwan. Respiratory Medicine. 2005(99):1079 - 86.

22. Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, et al.

Epidemiology of community-acquired pneumonia in adults: a population-

based study. European Respiratory Journal. 2000;15(4):757-63.

23. Cunha, A Burke.Community Acquired Pneumonia(Internet);2014(last

updated 2014 Januari 13, cited 2014 Januari 5).Available from :

www.emedicine.medscape.com/article/234240-overview#aw2aab6b4

24. National Health Service(Internet).United Kingdom : Pneumonia –

Causes;2012 (last reviewed 2012 Juni 15, cited 2013 23 Desember

2013).Available from : www.nhs.uk/conditions/pneumonia/pages/causes.aspx

25. ZS, Priyanti.Bagian Pulmonologi FK UI/RSUP Persahabatan Jakarta :

Konsensus Pneumonia(Internet); c2014 (cited 2014 Januari 5).Available from

: www.klikpdpi.com/konsensus/Xsip/konsensus-pneumonia/pneumonia.htm

26. Khalil MM, Abdel Dayem AM, Farghaly AAA-H, Shehata HM. Pattern of

community and hospital acquired pneumonia in Egyptian military hospitals.

Egyptian Journal of Chest Diseases and Tuberculosis. 2013;62(1):9-16.

67

27. Woodhead M. Community-acquired pneumonia in Europe: causative

pathogens and resistance patterns. European Respiratory Journal. 2002;20(36

suppl):20s-7s.

28. A.Mandell L, Wunderink R. Pneumonia. Harrison's Principles of Internal

Medicine. 2. 18th Edition ed. Jakarta: Penerbit Buku Kedokteran

EGC.2006.957 – 90 p.

29. Sylvia A.Price LMW. Patofisiologi : Konsep Klinis Proses - Proses Penyakit.

In: dr.Huriawati Hartanto dNS, dr.Pita Wulansari,dr.Dewi Asih Mahanani,

editor. 2. Jakarta: Penerbit Buku Kedokteran EGC.2002. p. 804 - 10.

30. Lynch JP, Zhanel GG. Streptococcus pneumoniae: Epidemiology, Risk

Factors, and Strategies for Prevention. Seminars in Respiratory and Critical

Care Medicine Thieme Medical Publishers 2009. p. 189-209

31. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, et al.

Etiology of community-acquired pneumonia: impact of age, comorbidity, and

severity. American Journal of Respiratory and Critical Care Medicine.

1999;160(2):397-405.

32. F.Simonetti A, Viasus D, Garcia-Vidal C, Carratala J. Management of

community-acquired pneumonia in older adults. Therapeutic Advances in

Infectious Disease. 2014;2(1):3- 16.

33. Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, et al.

Processes and outcomes of care for patients with community-acquired

pneumonia: results from the Pneumonia Patient Outcomes Research Team

(PORT) cohort study. Archives of internal medicine. 1999;159(9):970-80.

34. Sharma Sat, Maycher Bruce, Eschun Gregg.Radiological Imaging in

Pneumonia : Recent Innovations Imaging of Bacterial Pneumonia(Internet);

c2014(cited 2014 Januari 5). Available from :

www.medscape.org/viewarticle/556344_2

68

35. Boersma WG, Daniels J, Löwenberg A, Boeve W-J, van de Jagt EJ.

Reliability of radiographic findings and the relation to etiologic agents in

community-acquired pneumonia. Respiratory medicine. 2006;100(5):926-32.

36. Schmitt, Steven. Cleveland : Community Acquired Pneumonia(Internet);

c2014 (cited 2014 Januari 5).Available from :

www.clevelandclinicmed.com/medicalpubs/diseasemanagement/infectious-

disease/community-acquired-pneumonia/#bib10

37. Van der Eerden M, Vlaspolder F, De Graaff C, Groot T, Bronsveld W, Jansen

H, et al. Comparison between pathogen directed antibiotic treatment and

empirical broad spectrum antibiotic treatment in patients with community

acquired pneumonia: a prospective randomised study. Thorax.

2005;60(8):672-8.

38. Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG.

Efficacy of corticosteroids in community-acquired pneumonia: a randomized

double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181(9):975–

982.

39. Blasi F, Garau J, Medina J, Ávila M, McBride K, Ostermann H. Current

management of patients hospitalized with community-acquired pneumonia

across Europe: outcomes from REACH. Respir Res. 2013;14:44

40. Oosterheert JJ, Bonten MJ, Schneider MM, et al. Effectiveness of early switch

from intravenous to oral antibiotics in severe community acquired pneumonia:

multicentre randomised trial. BMJ. 2006;333(7580):1193.

41. Carratalà J, Garcia-Vidal C, Ortega L, Fernández-Sabé N, Clemente M,

Albero G, et al. Effect of a 3-step critical pathway to reduce duration of

intravenous antibiotic therapy and length of stay in community-acquired

pneumonia: a randomized controlled trial. Archives of internal medicine.

2012;172(12):922-8.

42. Song J-H, Oh WS, Kang C-I, Chung DR, Peck KR, Ko KS, et al.

Epidemiology and clinical outcomes of community-acquired pneumonia in

69

adult patients in Asian countries: a prospective study by the Asian network for

surveillance of resistant pathogens. International Journal of Antimicrobial

Agents(Internet). 2008 (cited 2013 Desember 20); 31(2):107–14.Available

from : www.sciencedirect.com/science/article/pii/S0924857907004888

43. Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN,

et al. Causes of death for patients with community-acquired pneumonia:

results from the Pneumonia Patient Outcomes Research Team cohort study.

Archives of Internal Medicine. 2002;162(9):1059-64.

44. Kikuchi, Ryo, et al. High incidence of silent aspiration in elderly patients with

community-acquired pneumonia. American Journal of Respiratory and

Critical Care Medicine. 1994; 150(1): 251-253.

45. Fung, Horatio B.; Monteaguda-Chu, Maricelle O. Community-acquired

pneumonia in the elderly. The American journal of geriatric pharmacotherapy.

2010; 8(1): 47-62.

46. Kaplan, V., Angus, D. C., Griffin, M. F., Clermont, G., Scott Watson, R. &

Linde – Zwirble, W.T.Hospitalized community-acquired pneumonia in the

elderly: age-and sex-related patterns of care and outcome in the United States.

American journal of respiratory and critical care medicine.2002;165 : 766-

772.

47. Torres, A., Peetermans, W. E., Viegi, G., & Blasi, F. Risk factors for

community-acquired pneumonia in adults in Europe: a literature review.

Thorax. 2013; 68(11) : 1057-1065.

48. Corrales-Medina, V. F., Musher, D. M., Shachkina, S., & Chirinos, J. A.Acute

pneumonia and the cardiovascular system. The Lancet.2013; 381(9865) : 496-

505.

49. Falguera, Miquel, et al. Etiology and outcome of community-acquired

pneumonia in patients with diabetes mellitus. CHEST Journal.2005; 128(5):

3233-323

70

50. Saibal, M. A. A., Rahman, S. H. Z., Nishat, L., Sikder, N. H., Begum, S. A.,

Islam, M. J., & Uddin, K. N. Community acquired pneumonia in diabetic and

non-diabetic hospitalized patients: presentation, causative pathogens and

outcome. Bangladesh Medical Research Council Bulletin. 2013; 38(3) : 98-

103.

51. Bansal, S., Kashyap, S., Pal, L. S., & Goel, A.Clinical and bacteriological

profile of community acquired pneumonia in Shimla, Himachal Pradesh.

Indian Journal of Chest Diseases and Allied Sciences.2004; 46(1) : 17-22.

52. Furer, V., Raveh, D., Picard, E., Goldberg, S., & Izbicki, G.Absence of

leukocytosis in bacteraemic pneumococcal pneumonia. Prim Care Respir J.

2011; 20(3) : 276-281.

53. Khalil, M. M., Abdel Dayem, A. M., Farghaly, A. A. A. H., & Shehata, H. M.

Pattern of community and hospital acquired pneumonia in Egyptian military

hospitals. Egyptian Journal of Chest Diseases and Tuberculosis.2013; 62(1) :

9-16.

54. Kolditz, M., Halank, M., & Höffken, G. 2006. Monotherapy versus

combination therapy in patients hospitalized with community-acquired

pneumonia. Treatments in respiratory medicine. 2006; 5(6) : 371-383.

55. Nair, G. B., & Niederman, M. S. Community-acquired pneumonia: an

unfinished battle. Medical Clinics of North America. 2011; 95(6) : 1143-

1161.

71

Lampiran 1

72

Lampiran 2

73

74

Lampiran 3

Biodata Mahasiswa

Identitas

Nama : Nur Muhamad Arjanardi

NIM : 22010110120064

Tempat tanggal lahir : Kabupaten Semarang, 27 September 1992

Jenis Kelamin : Laki-laki

Alamat : Jl. Parasamya IV-94, perumda, Ungaran

No. HP : 085726838946

Email : nurmuhamad30@gmail.com

Riwayat Pendidikan Formal :

1. SD : SDN UNGARAN 1 Lulus tahun: 2004

2. SMP : SMP N 1 UNGARAN Lulus tahun: 2007

3. SMA : SMA TARUNA NUSANTARA Lulus tahun: 2010

4. SI : Fakultas Kedokteran Universitas Diponegoro Masuk : 2010

Riwayat Organisasi

1. HIMA KU UNDIP

2. ISMKI

75

Lampiran 4